Research programme: small molecule enzyme inhibitors - OncoTherapy ScienceAlternative Names: Methyltransferase SUV39H2 inhibitors - OncoTherapy Science; OTS-514; OTS-964; T-LAK cell-originated protein kinase inhibitors - OncoTherapy Science; TOPK inhibitors - OncoTherapy Science
Latest Information Update: 04 Apr 2016
At a glance
- Originator OncoTherapy Science
- Developer OncoTherapy Science; University of Chicago
- Class Small molecules
- Mechanism of Action Methyltransferase inhibitors; PDZ-binding kinase inhibitors; Protein kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Acute myeloid leukaemia; Cancer